Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  2'-DEOXY-L-CYTIDINE

2'-DEOXY-L-CYTIDINE

Basic information Safety Supplier Related

2'-DEOXY-L-CYTIDINE Basic information

Product Name:
2'-DEOXY-L-CYTIDINE
Synonyms:
  • BETA-L-2'-DEOXYCYTIDINE
  • 4-AMino-1-((2R,4R,5S)-4-hydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)pyriMidin-2(1H)-one
  • L-2'-deoxycytidine
  • 2'-DEOXY-L-CYTIDINE
  • 4-amino-1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
  • 2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-b-L-erythro-pentofuranosyl)-
  • 2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-β-L-erythro-pentofuranosyl)-
  • Torcitabine
CAS:
40093-94-5
MF:
C9H13N3O4
MW:
227.22
EINECS:
500-100-4
Mol File:
40093-94-5.mol
More
Less

2'-DEOXY-L-CYTIDINE Chemical Properties

Boiling point:
497.6±55.0 °C(Predicted)
Density 
1.73±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO: 250 mg/mL (1100.26 mM)
pka
14.03±0.60(Predicted)
form 
Solid
color 
White to off-white
Water Solubility 
Water: 250 mg/mL (1100.26 mM)
More
Less

2'-DEOXY-L-CYTIDINE Usage And Synthesis

Description

Torcitabine (b-L-2u-deoxycytidine) (L-dC) is the b-L-enantiomer of the natural nucleoside D-cytidine. The drug is currently under development by Idenix as an antiviral agent for the treatment of chronic hepatitis B virus infection. Torcitabine has poor oral bioavailability, but its 3u,5u-divaline ester (val-L-dC) and the 3u-monovaline ester, valtorcitabine dihydrochloride, have excellent oral bioavailability and consequently the torcitabine prodrug, valtorcitabine, has replaced torcitabine in clinical development.

Uses

Torcitabine and its prodrug, valtorcitabine, are investigational drugs being developed solely for the treatment of chronic HBV infection. Torcitabine itself has undergone preliminary phase I/II clinical trials in HBeAg-positive patients, initially as the 3u,5u-divalyl prodrug in escalating doses of 50, 100, 200, and 400 mg/day, but later as the more stable monovaline ester form, valtorcitabine dihydrochloride, and administered to four cohorts in doses of 300, 600, 900, and 1200 mg/ day for 28 days.

2'-DEOXY-L-CYTIDINESupplier

Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
021-51613915-820 13611835272
Email
mmwang@sunwaypharm.cn
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 18892239720
Email
psaitong@jm-bio.com
Aikon International Limited
Tel
025-58851090 13611564524
Email
lwan@aikonchem.com
Wuhu Huaren Science and Technology Co., Ltd.
Tel
0553-0553-5842013-801 18155347026
Email
jinhuaren@huarensh.com